“Cash-strapped states are scaling back efforts to provide life-saving medicines to HIV patients.”
In this article, Shefali S. Kulkarni somewhat frighteningly explains that in an effort to save money, some states are changing eligibility, cutting back on waiting lists, and decreasing the availability of antiretrovial drugs for AIDS patients. This means that thousands of people cannot get the drugs they need.
Experts say this plan may save money now but will ultimately backfire, because patients with access to antiretroviral drugs are better able to manage the disease and may even be less infectious, thus lowering costs in the long run.
AIDSTanzania 